tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TARS Stock Latest News

Tarsus Pharmaceuticals Holds Annual Stockholders Meeting
Company AnnouncementsTarsus Pharmaceuticals Holds Annual Stockholders Meeting
9d ago
8K
TARS
Tarsus Pharmaceuticals: Promising Outlook with Successful Xdemvy Launch and Strategic Growth Initiatives
PremiumRatings
Tarsus Pharmaceuticals: Promising Outlook with Successful Xdemvy Launch and Strategic Growth Initiatives
24d ago
TARS
Tarsus Pharmaceuticals assumed with an Outperform at Oppenheimer
PremiumThe Fly
Tarsus Pharmaceuticals assumed with an Outperform at Oppenheimer
25d ago
TARS
Promising Growth Trajectory of Tarsus Pharmaceuticals: Buy Rating Supported by Unique Product Positioning and Strong Market Presence
PremiumRatings
Promising Growth Trajectory of Tarsus Pharmaceuticals: Buy Rating Supported by Unique Product Positioning and Strong Market Presence
1M ago
TARS
Tarsus Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Tarsus Pharmaceuticals assumed with a Buy at H.C. Wainwright
1M ago
TARS
Elanco sells royalty, milestone rights for Xdemvy to Blackstone for $295M
PremiumThe FlyElanco sells royalty, milestone rights for Xdemvy to Blackstone for $295M
2M ago
BX
ELAN
Tarsus Pharmaceuticals’ Earnings Call Highlights Robust Growth
Premium
Company Announcements
Tarsus Pharmaceuticals’ Earnings Call Highlights Robust Growth
2M ago
TARS
Tarsus Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
Premium
Ratings
Tarsus Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
2M ago
TARS
Tarsus Pharmaceuticals price target raised to $84 from $78 at Guggenheim
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $84 from $78 at Guggenheim
2M ago
TARS
Tarsus Pharmaceuticals Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Tarsus Pharmaceuticals Reports Strong Q1 2025 Growth
2M ago
TARS
Tarsus Pharmaceuticals reports Q1 EPS (64c), consensus (63c)
PremiumThe Fly
Tarsus Pharmaceuticals reports Q1 EPS (64c), consensus (63c)
2M ago
TARS
Tarsus Pharmaceuticals to present abstracts on XDEMVY at ASCRS meeting
PremiumThe Fly
Tarsus Pharmaceuticals to present abstracts on XDEMVY at ASCRS meeting
2M ago
TARS
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
PremiumThe FlyTarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
4M ago
TARS
Tarsus Pharmaceuticals announces $100M common stock offering
Premium
The Fly
Tarsus Pharmaceuticals announces $100M common stock offering
4M ago
TARS
Tarsus Pharmaceuticals price target raised to $58 from $54 at Jefferies
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $58 from $54 at Jefferies
4M ago
TARS
Tarsus Pharmaceuticals’ Earnings Call Highlights Success and Challenges
PremiumCompany Announcements
Tarsus Pharmaceuticals’ Earnings Call Highlights Success and Challenges
4M ago
TARS
Hold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
PremiumRatings
Hold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
4M ago
TARS
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
PremiumThe Fly
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
4M ago
TARS
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
PremiumRatings
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
4M ago
TARS
Tarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
PremiumRatingsTarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
4M ago
TARS
Tarsus Pharmaceuticals price target lowered to $60 from $62 at Barclays
Premium
The Fly
Tarsus Pharmaceuticals price target lowered to $60 from $62 at Barclays
4M ago
TARS
Tarsus Pharmaceuticals Reports Strong 2024 Financial Results
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Strong 2024 Financial Results
4M ago
TARS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >